18 kinds of special drugs are included in the scope of compensation for major diseases insurance
Shandong commercial newspaper reporter Wang Xiaodi
recently, provincial agency hall, Provincial Department of Finance issued the report on the related issues of medical expenses compensation for big disease insurance (Trial) "(Lu people's social rules [2017] 8), explicitly put 18 special drugs such as Decitabine for Injection into the coverage of serious illness insurance funds. In addition, the compensation for serious illness insurance costs in 2017 was calculated from January 1st. The cost of special drugs for insured patients in different places is compensated according to the medical insurance settlement price stipulated by special drugs in our province and the relevant provisions. Most of these 18 special drugs are targeted drugs for cancer treatment, and the price is high. A resident suffering from lung cancer told reporters that he needed to take Gefitinib Tablets for a long time. This is a targeted drug used for the treatment of advanced lung adenocarcinoma. "The price of 200 yuan per piece will be more than 50 thousand in one year, and it will be saved by more than 20000 in one year."
these 18 kinds of special drugs include: Gefitinib Tablets, Decitabine for Injection, Bortezomib for Injection, Lenalidomide capsules, Pegaspargase Injection, Dasatinib Tablets, Icotinib Hydrochloride Tablets, reject, bevacizumab. Injection, Cetuximab Solution for Infusion, rimetril for injection, sultinib malate, apatinib mesylate, Bosentan Tablets, recombinant human coagulation factor IX and Tenofovir disoproxil fumarate tablets for injection.